Mallet V - Search Results

1

Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141).

Deuffic-Burban S, Schwarzinger M, Obach D, Mallet V, Pol S, Pageaux GP, Canva V, Deltenre P, Roudot-Thoraval F, Larrey D, Dhumeaux D, Mathurin P, Yazdanpanah Y. Deuffic-Burban S, et al. Among authors: mallet v. J Hepatol. 2014 Jul;61(1):7-14. doi: 10.1016/j.jhep.2014.03.011. Epub 2014 Mar 17. J Hepatol. 2014. PMID: 24650691

2

FIB-4: a simple, inexpensive and accurate marker of fibrosis in HCV-infected patients.

Vallet-Pichard A, Mallet V, Pol S. Vallet-Pichard A, et al. Among authors: mallet v. Hepatology. 2006 Sep;44(3):769; author reply 769-70. doi: 10.1002/hep.21334. Hepatology. 2006. PMID: 16941681 No abstract available.

3

Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients.

Mallet V, Blanchard P, Verkarre V, Vallet-Pichard A, Fontaine H, Lascoux-Combe C, Pol S. Mallet V, et al. AIDS. 2007 Jan 11;21(2):187-92. doi: 10.1097/QAD.0b013e3280119e47. AIDS. 2007. PMID: 17197809

4

FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest.

Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, Fontaine H, Pol S. Vallet-Pichard A, et al. Among authors: mallet v. Hepatology. 2007 Jul;46(1):32-6. doi: 10.1002/hep.21669. Hepatology. 2007. PMID: 17567829

5

Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy.

Zeitoun JD, Mallet V, Chaix ML, Viard JP, Blanche S, Pol S. Zeitoun JD, et al. Among authors: mallet v. J Clin Virol. 2007 Sep;40(1):71-3. doi: 10.1016/j.jcv.2007.05.014. Epub 2007 Jul 19. J Clin Virol. 2007. PMID: 17658294

6

[A puzzling case of portal hypertension in a patient with human immunodeficiency and hepatitis C virus co-infection].

Mallet V, Pol S. Mallet V, et al. Gastroenterol Clin Biol. 2007 Oct;31(10):878-80. doi: 10.1016/s0399-8320(07)73984-2. Gastroenterol Clin Biol. 2007. PMID: 18166872 Free article. French.

7

Serum alpha-fetoprotein predicts treatment outcome in chronic hepatitis C patients regardless of HCV genotype.

Abdoul H, Mallet V, Pol S, Fontanet A. Abdoul H, et al. Among authors: mallet v. PLoS One. 2008 Jun 11;3(6):e2391. doi: 10.1371/journal.pone.0002391. PLoS One. 2008. PMID: 18545682 Free PMC article.

8

Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib.

Mir O, Coriat R, Boudou-Rouquette P, Ropert S, Durand JP, Cessot A, Mallet V, Sogni P, Chaussade S, Pol S, Goldwasser F. Mir O, et al. Among authors: mallet v. Med Oncol. 2012 Dec;29(4):2793-9. doi: 10.1007/s12032-012-0208-x. Epub 2012 Mar 17. Med Oncol. 2012. PMID: 22427209

9

Nonalcoholic fatty liver disease and HIV infection.

Vallet-Pichard A, Mallet V, Pol S. Vallet-Pichard A, et al. Among authors: mallet v. Semin Liver Dis. 2012 May;32(2):158-66. doi: 10.1055/s-0032-1316471. Epub 2012 Jul 3. Semin Liver Dis. 2012. PMID: 22760655 Review.

10

Management of hepatitis C virus infection in heavy drinkers.

Costentin CE, Trabut JB, Mallet V, Darbeda S, Thépot V, Nalpas B, Badin de Montjoye B, Lavielle B, Vallet-Pichard A, Sogni P, Pol S. Costentin CE, et al. Among authors: mallet v. Alcohol Alcohol. 2013 May-Jun;48(3):337-42. doi: 10.1093/alcalc/agt020. Epub 2013 Mar 21. Alcohol Alcohol. 2013. PMID: 23518789

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters